T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitis
Robert C. Axtell(Stanford University), Brigit A. de Jong(Radboud University Nijmegen), Katia Boniface(CTI BioPharma (Italy)), L.F. van der Voort(Amsterdam UMC Location VUmc), R. Bhat(Stanford University), Patrizia De Sarno(University of Alabama at Birmingham), Rodrigo Naves(University of Alabama at Birmingham), May Han(Stanford University), Franklin L. Zhong(Stanford University), Jim G. Castellanos(Stanford University), Robert D. Mair(Stanford University), Athena Christakos(Stanford University), Ilan Kolkowitz(Stanford University), Liat Katz(Stanford University), Joep Killestein(Amsterdam UMC Location VUmc), Chris H. Polman(Amsterdam UMC Location VUmc), René de Waal Malefyt(CTI BioPharma (Italy)), Lawrence Steinman(Stanford University), Chander Raman(University of Alabama at Birmingham)
Cited by 532Open Access
Abstract
Related Papers
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Claire L. Langrish, Yi Chen, Wendy M. Blumenschein et al.|The Journal of Experimental Medicine|2005|4k